RE:RE:RE:RE:RE:RE:Quick math for those interestedNo hate, although they did fail to deliver the 100mm 2019 Bruce Campbell was screaming about, and the 40mm clarification Brayden mentioned shortly after the out to lunch sales target. Not to mention the newest, operational CBD lab that’s still not functional. Besides this running flat for 2 years, I’m sure there’s going to come a time where the SP finally does get a moderate bump, even with approaching a monster 300mm shares?
As as for myself, I’ve done well purchasing an initial 200k shares at avg 0.187, then exiting briefly for a 250k purchase on the way down for an even lower avg of 11 cents CAD. Yes I bought at bottom and timed it perfectly, me and Mangler both did well.
To be realistic, this stock is going to have great difficulty, breaking a 300mm - 400mm cap due to multiple variable including the nasty dilution Brayden has brought upon thow lol.
I’m sitting on the sidelines watching all over again, but for the time being I can find many other undervalued low float LPs with lower caps and higher revenue, even with the newest 1933 (Partial) operational facility accounted for.
But not to worry, if I can time it perfectly and jump back in to score a quick double I will.
Just tired of my money sitting idle while it can be working for me.